Microbiome- Competitive Landscape, Technology and Pipeline
Analysis, 2017
Chemotherapy Induced Nausea and Vomiting (CINV)- Epidemiology Insights-2023” Report provides an overview of the
disease, historical and forecasted epidemiological data for the Incident cases of Chemotherapy Induced Nausea and
Vomiting (CINV) from 2013-2023 for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan.
Chemotherapy-induced nausea and vomiting (CINV) are both severe side effects of cancer treatment. CINV is a condition
which makes a patient uncomfortable and has to be dealt properly as many patients delay their chemotherapy cycles or
even refuse further treatment due to fear from future nausea and vomiting. Also, due to nausea and vomiting induced by
chemotherapy, patients can't get nutrition properly and lose their energy and may become weak which may hinder the
further chemotherapy cycles as patient wouldn't be physically string to bear the chemotherapy side-effects.
According to, the Incident cases Chemotherapy Induced Nausea and Vomiting (CINV) is increasing and is expected to be 2,
79,634 by 2023.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-
house Forecast model analysis by Publisher team of industry experts.
Browse Complete Report at : http://www.reportsnreports.com/reports/942655-microbiome-competitive-landscape-
technology-andpipeline-analysis-2017.html